Trial intelligence / Profile preview

First-in-human IDRX-42 study in metastatic or unresectable gastrointestinal stromal tumors

NL-OMON60322Phase 2Active, not recruiting

Sponsor

IDRx

Start

Apr 2024

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1